Active Ingredient History
Ganaxolone, sold under the brand name Ztalmy, is a medication used to treat seizures in people with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder. Ganaxolone is a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Behavioral Symptoms (Phase 2)
Deficiency Diseases (Phase 3)
Depression (Phase 2)
Depression, Postpartum (Phase 2)
Depressive Disorder (Phase 2)
Epilepsies, Partial (Phase 2)
Epilepsy (Phase 3)
Epilepsy, Complex Partial (Phase 2)
Fragile X Syndrome (Phase 2)
Mental Disorders (Phase 2)
Mood Disorders (Phase 2)
Postpartum Period (Phase 2)
Pregnancy Complications (Phase 2)
Puerperal Disorders (Phase 2)
Seizures (Phase 3)
Smoking Cessation (Phase 2)
Spasms, Infantile (Phase 2)
Status Epilepticus (Phase 3)
Stress Disorders, Post-Traumatic (Phase 2)
Tuberculin (Phase 2)
Tuberous Sclerosis (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
